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1. Introduction 
Embryonic stem cells (ESCs) are pluripotent and self-renewing cells that are derived from 
the inner cell mass (ICM) of the developing blastocysts (Evans and Kaufman, 1981; Martin, 
1981). ESCs have the ability to maintain self-renewal and to differentiate into all types of 
cells. With respect to primates, ESCs were first established from the rhesus monkey (Macaca 
mulatta) (Thomson et al., 1995) and subsequently from humans (Thomson et al., 1998). 
Human ESCs are of particular interest because of their potential application to regenerative 
medicine and drug discovery. In addition, human ESCs may provide insights into human 
embryo development in culture. Therefore, identification of the molecular mechanisms that 
govern human ESC self-renewal, differentiation and proliferation is of considerable interest.  
A small number of genes, the so-called ”core transcription factors”, is thought to have a 
central role in the control of the stem cell state in concert with other genes including other 
transcription factors. The ESC state is largely governed by three core transcription factors, 
OCT4, SOX2, and NANOG. In the mouse, Oct4 and Nanog have a distinctive expression 
pattern in ESCs and during embryonic development, and genetic and molecular analyses 
have shown that both genes have essential roles for maintaining the stable pluripotent state 
(Chambers et al., 2003; Mitsui et al., 2003; Nichols et al., 1998; Niwa et al., 2000). By contrast, 
Sox2 is widely expressed during embryonic development and occurs not only in the inner 
cell mass and epiblast but also in neural tissues, extra embryonic ectoderm, gut endoderm, 
esophagus and trachea (Avilion et al., 2003; Williamson et al., 2006; Wood and Episkopou, 
1999). Indeed, SOX2 is required for development during the peri-implantation period, and 
is required for trophoblast formation and neural development (Avilion et al., 2003; 
Kelberman et al., 2006; Taranova et al., 2006). Oct4 acts as a heterodimer with Sox2 in mouse 
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ESCs; Sox2 assigns a position for key regulators for the maintenance of mouse ESCs with 
undifferentiated state (Ambrosetti et al., 2000; Avilion et al., 2003; Masui et al., 2007).  
Mouse ESCs have often been used as a model system for human ESCs. However, various 
differences are known to exist between the ESCs of the two species, including the molecular 
mechanisms for self-renewal. For example, the LIF/STAT3 pathway is involved in mouse ESC 
self-renewal (Niwa et al., 1998), but is dispensable in human ESCs (Daheron et al., 2004; 
Humphrey et al., 2004). Moreover, BMP4 signaling is required for the maintenance of self-
renewal in mouse ESCs grown in serum-free medium, and acts by inhibiting neural 
differentiation (Ying et al., 2003). However, the addition of BMP4 to human ESC culture 
promotes primitive endoderm or trophectoderm differentiation (Pera et al., 2004; Xu et al., 
2002). These inter-species differences have become a highly contentious issue following the 
establishment of a new type of pluripotent cell line called EpiSCs (Brons et al., 2007; Tesar et 
al., 2007). EpiSCs were first established by explanting late epiblast from mouse embryos; these 
explanted cells expressed the core transcription factors Oct4, Sox2 and Nanog. EpiSCs can 
differentiate into three germ layers but they are inefficient in generating chimeras, suggesting 
that they have a more limited developmental potential than ESCs. Interestingly, mouse EpiSCs 
and human ESCs have similar growth requirements and gene expression patterns, and both 
types of cells are distinguishable from mouse ESCs. It is unclear whether human ESCs are 
really a counterpart of mouse EpiSCs, since EpiSCs have not been extensively studied to date.  
Disregarding the issue of EpiSCs, mouse and human ESCs are believed to have similar 
molecular mechanisms for maintenance of the undifferentiated state. Chromatin 
immunoprecipitation (ChIP) assays combined with genome-wide location methodologies 
showed that in both human and mouse ESCs, OCT4, SOX2 and NANOG have common 
target sites within the regulatory regions of many genes. This is true of active, highly 
expressed genes, such as OCT4, SOX2 and NANOG themselves, and inactive genes, such as 
developmental regulators that maintain the pluripotent state (Boyer et al., 2005; Loh et al., 
2006). Downregulation of OCT4 in mouse and human ESCs induces trophectoderm 
differentiation (Babaie et al., 2007; Hay et al., 2004; Matin et al., 2004; Niwa et al., 2000; 
Zaehres et al., 2005). By contrast, overexpression of OCT4 induces ESCs to differentiate into 
endoderm or mesoderm cells (Niwa et al., 2000; Rodriguez et al., 2007). Reduction in 
expression of NANOG in mouse ESCs induces endoderm differentiation (Chambers et al., 
2003; Mitsui et al., 2003), while in human ESCs, it induces both endoderm and 
trophectoderm differentiation (Hyslop et al., 2005; Zaehres et al., 2005). Overexpression of 
NANOG promotes stabilization of an undifferentiated state in ESCs. Mouse ESCs can 
maintain an undifferentiated state in the absence of LIF (Chambers et al., 2003; Chambers et 
al., 2007; Mitsui et al., 2003). The human ESCs allows feeder-free growth or growth without 
conditioned medium from feeder cells (Darr et al., 2006). In mouse ESCs, repression of Sox2 
expression induces trophectoderm differentiation (Masui et al., 2007), whereas 
overexpression induces non-specific lineage differentiation, neuronal differentiation or 
massive cell death (Kopp et al., 2008; Mitsui et al., 2003; Zhao et al., 2004). Furthermore, 
Sox2-deficient mice are defective in the maintenance of ICM/epiblast and trophoblast 
development (Avilion et al., 2003), leading to the conclusion that SOX2 may have an 
important role in trophoblast development as well as in ESC maintenance. However, the 
role of SOX2 in human ESCs is not fully understood.  
Reprogramming of somatic cells into induced pluripotent stem (iPS) cells provides another 
approach to investigating the nature of the undifferentiated state in ESCs. Surprisingly, the 
overexpression of only four transcription factors, Oct4, Sox2, Klf4 and c-Myc, can convert 
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somatic fibroblasts to pluripotent cells that can contribute to the germline in chimeric mice, 
similarly to ESCs (Okita et al., 2007; Takahashi and Yamanaka, 2006; Wernig et al., 2007). 
Reprogramming can be induced not only by Oct4, Sox2, Klf4 and c-Myc but also by use of 
combinations including Nanog, Lin28 and other genes. Generally, overexpression of Sox2 is 
required unless the somatic cells already have endogenous Sox2 expression (Hanna et al., 
2010; Stadtfeld and Hochedlinger, 2010). Moreover, the level of SOX2 expression has a direct 
effect on the rate of direct reprogramming of somatic cells to iPSCs (Yamaguchi et al., 2011). 
These results provide further support for the assumption that SOX2 has a definitive role in 
the maintenance of ESCs.  
In this study, we investigated the role of SOX2 in human ESCs by manipulating the level of 
SOX2 expression. We show that depletion or overexpression of SOX2 in human ESCs 
induced trophectoderm differentiation. We further showed that overexpression of SOX2 
during human ESC differentiation promoted neural and glandular epithelium development.  
2. The role of SOX2 in maintaining pluripotency and differentiation of human 
ESCs 
2.1 The role of SOX2 in maintaining pluripotency of human ESCs 
2.1.1 Depletion of SOX2 in human ESCs induces trophectodermal and some 
endodermal differentiation 
To investigate the role of SOX2 in human ESCs, we used a small interfering RNA (siRNA) to 
knockdown gene expression. We first optimized the protocol by examining the effect of a 
previously described siRNA on OCT4 expression in the KhES1 cell line (Dharmacon ID D-
019591-05) (Babaie et al., 2007) (a detailed protocol is described in Adachi et al., 2010). This 
siRNA reduced OCT4 expression in our protocol as determined by quantitative real-time PCR 
(Q-PCR) (Figure 1A) and Western blotting (40-, 44-kDa signal, Figure 1B), indicating that this 
protocol was appropriate for the study. Next, we analyzed the levels of SOX2 expression in 
KhES1 cells transfected with a range of siRNAs, since selection of appropriate siRNA 
sequences was crucial to the study. Overall, we found that D-011778-01 siRNA (Dharmacon) 
was the most effective of the tested siRNAs.  A Q-PCR analysis indicated that D-011778-01 
siRNA reduced SOX2 mRNA expression to 25% of the control level (Fig. 1A). Western blotting 
confirmed a reduction in the level of SOX2 protein in the cells (34-kDa signal, Figure 1B). SOX2 
repression in human ESCs caused changes to cell morphology from 48 hours post-transfection. 
Cells with enlarged nuclei and a flattened morphology were present after 72 hours. These 
morphological changes were accompanied by a reduction in the SOX2 protein level as 
determined by immunohistochemistry (Fig. 1C). In addition, the cells showed downregulated 
expression of ESC-specific surface markers, anti-stage specific embryonic antigen (SSEA)-4, 
anti-tumor rejection antigens (TRA)-1-60 and TRA-1-81, and also upregulated expression of 
the differentiation marker SSEA-1 (Fig. 1D, and data not shown). These results indicate that 
SOX2 expression may be required for maintenance of human ESCs in a pluripotent state.   
As mentioned earlier, three core transcription genes, OCT4, SOX2 and NANOG, are thought 
to form an interconnected autoregulatory loop in human ESCs (Boyer et al., 2005; Loh et al., 
2006). In agreement with previous reports, OCT4 knockdown in human ESCs caused a 
decrease in both NANOG and SOX2 levels to 10-30% of the control level, indicating that 
OCT4 may regulate expression of these core transcription factors. In the KhES1 cells with 
knockdown of SOX2, the OCT4 transcript level was slightly decreased, while the NANOG 
level decreased to 60% of the control (Fig. 1A). When we examined another human ESC line, 
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HES-3, we found that D-011778-01 siRNA reduced SOX2 expression to 28% of the control. In 
this cell line, the OCT4 and NANOG transcript levels decreased to 60% and 55% of the 
control, respectively. These results indicate that SOX2 may play a role in regulating 
expression of NANOG and, perhaps, OCT4. Future studies using SOX2-deficient human 
ESCs should provide conclusive evidence on whether SOX2 regulates the expression of 
OCT4 and NANOG.  
Our data indicate that SOX2 expression is required to maintain human ESCs in an 
undifferentiated state, although the exact differentiation status of the cells was uncertain. 
Immunohistochemical analysis showed that the majority of SOX2 downregulated cells 
(98.5%, n = 200) were positive for the trophectodermal marker cytokeratin 8, and a small 
population of cells with downregulation of SOX2 were positive for the endodermal marker 
GATA6 (0.8%, n = 1,000) (Fig. 1E). We could not detect any increase in other linage markers 
including the ectodermal marker PAX6 and the mesodermal marker brachyury (T) homolog 
(K.A. and E.K., unpublished observation). Q-PCR showed that SOX2 knockdown in human 
ESCs resulted in upregulation of the trophectodermal markers EOMES, BMP4 and HAND1 
at 72 hours after transfection. Interestingly, CDX2 was not significantly upregulated (Fig. 
1F). Upregulation of trophectodermal markers, except CDX2, was also present at 48 hours 
after transfection. At this time point, GATA3 was upregulated (Fig 1G). GATA3 is a gene 
expressed in the trophectoderm; Gata3 directly regulates Cdx2 transcription via a conserved 
GATA motif at the intron 1 region of the Cdx2 locus in the mouse (Home et al., 2009). Thus, 
CDX2 shows an exceptional expression pattern compared to other early trophectodermal 
markers, possibly indicating that in these cells some other gene may be involved in its 
regulation. We also found that expression of the endodermal markers GATA6 and FOXA2 
was upregulated in cells with downregulation of SOX2 (Fig. 1F). Furthermore, expression of 
ectodermal and mesodermal markers in SOX2 siRNA transfected cells was not significantly 
altered relative to controls. However, we observed that the ectodermal marker OTX1 and 
the mesodermal marker VIM were upregulated. Thus, the results from assays of transcripts 
were consistent with the immunohistological observations. Taken together with similar 
results from the HES-3 cell line, we conclude that SOX2 expression maintains ESC 
pluripotency by suppressing trophectodermal and, to a lesser extent, endodermal 
differentiation.   
It was previously shown that reduction in SOX2 expression in human ESCs resulted in the 
loss of the undifferentiated state with an associated increase in the expression of 
trophectoderm lineage markers including CDX2 (Fong et al., 2008). However, in this study, 
human ESCs were cultured with mouse MEF feeder cells; consequently, it was not possible 
to exclude the possibility that the feeder cells also influenced the undifferentiated or 
differentiated state of the ESCs. In this study, we used a feeder-free culture system and were 
thus able to address directly the effect of SOX2 reduction on human ESCs. Our results 
without feeder cells showed that CDX2 was not upregulated in cells with suppressed 
expression of SOX2; this finding is consistent with previous results from ES cells of the Sox2 
null mouse (Masui et al., 2007). Furthermore, our results were the first to show that a 
reduction in SOX2 expression in human ESCs specifically caused differentiation of 
endoderm as well as trophectoderm. A lack of SOX2 has been found to induce 
differentiation into trophectoderm or extraembryonic endoderm cells from the 
ICM/epiblast lineage in mouse embryos (Avilion et al., 2003), consistent with our results in 
human ESCs. Thus, we believe that feeder cells may bias against the intrinsic lineage 
differentiation in human ESCs. Our analysis of human ESCs in a feeder cell-free culture 
www.intechopen.com
The Role of SOX2 in Maintaining Pluripotency 
and Differentiation of Human Embryonic Stem Cells 
 
173 
system identified new roles for SOX2. Clearly, this system could be also be used to 










Fig. 1. Depletion of SOX2 in human ESCs induces trophectodermal and some endodermal 
differentiation.  
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Transfection with SOX2 siRNA reduced SOX2 mRNA levels to approximately 25% of the 
negative control (Nega Control siRNA). OCT4 and NANOG mRNA levels also decreased. 
(B) Western blotting analysis of SOX2 protein levels at 72 hours after siRNA transfection. 
Both mouse and human SOX2 protein was detected as a 34 kDa band (indicated by arrow). 
Decreased levels of SOX2 protein was present in human ESCs after transfection with SOX2 
or OCT4 siRNAs. Lamin B1 and GAPDH was used as loading controls.  (C) Morphology of 
KhES1 cells 72 hours after transfection with either Nega Control siRNA or SOX2 siRNA. The 
level of SOX2 protein was confirmed by immunohistochemistry. (D) SOX2 knockdown cells 
showed downregulation of the ESC-specific surface marker SSEA-4 and upregulation of the 
differentiation marker SSEA-1. (E) Immunohistochemical detection of the trophectodermal 
marker cytokeratin 8 (98.5%, n = 200) and endodermal marker GATA6 (0.8%, n = 1,000) in 
SOX2-downregulated cells. (F, G) SOX2 knockdown in human ESCs resulted in 
upregulation of the trophectodermal markers EOMES, BMP4 and HAND1 (F, G) and 
endodermal markers GATA6 and FOXA2 (F).  The Q-PCR data (A, D) represent the means 
(white bar for Nega control siRNA, and gray bar for SOX2 siRNA) ± SEM relative to the 
negative control (=1.0). The assays were normalized to GAPDH. The transfection 
experiments were carried out three times in triplicate (n = 9) for KhES1 cells (A, E) and twice 
(n = 6) for HES-3 cells (A). Statistical significance of the results was assessed using the 
Student’s t-test. Scale bars = 100 mm (C, D, E).  Analyses were performed at 48 hours (G) or 
72 hours (others) after transfection. Abbreviations: GSC, goosecoid homeobox. This figure is 
modified from (Adachi et al., 2010).  
2.1.2 Overexpression of SOX2 in human ESCs induces trophectodermal 
differentiation 
We used a lipofection method to induce transient SOX2 overexpression in human ESCs and 
analyzed the effects with an RT-PCR analysis (Adachi et al., 2010). We monitored SOX2 
expression for 72 hours after transfection. SOX2 expression levels peaked at 24 hours post-
transfection and, thereafter, the levels decreased. An immunohistochemical analysis 
indicated that about 20% of the human ESCs overexpressed the SOX2 protein. When 
compared with wild type or mock transfected cells, SOX2 overexpressing cells showed 
significant upregulation of the early trophectodermal markers EOMES or CDX2, but not of 
later trophectodermal markers, such as BMP4 or the glycoprotein hormones alpha chain. By 
contrast, the expression patterns were not changed in the endodermal markers GATA6 and 
alpha-fetoprotein (AFP), the mesodermal markers goosecoid homeobox (GSC) and 
brachyury (T) homolog or the ectodermal markers PAX6, OTX1 and OTX2. Interestingly, we 
did not detect significant downregulation of the pluripotency markers OCT4 and NANOG. 
Thus, transient overexpression of SOX2 in human ESCs may induce expression of early 
trophectodermal genes, but this was not sufficient for re-specification of the cells into the 
trophectoderm lineage.  
In order to achieve constitutive overexpression of SOX2 in human ESCs, we used the Tet-
On/Off system of monkey ESCs and developed this for human ESCs (Adachi et al., 2006; 
Adachi et al., 2010). We isolated two independent cell lines (#14 and #27) that showed 
doxycycline (Dox)-induced SOX2 expression in a dose-dependent manner. Human ESCs, in 
general, are sensitive to chemicals and we found that high levels of Dox (more than 
2 mg/ml) had some detrimental effects on the survival of wild-type human ESCs (data not 
shown). Therefore, we used 1 mg/ml Dox in our experiments. Human ES clones #14 and 
#27 were morphologically indistinguishable from parental KhES1 ESCs when cultured 
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under standard human ESC culture conditions. The addition of 1 mg/ml Dox to the 
medium resulted in a two- to four-fold increase in SOX2 expression (as determined by Q-
PCR) on day 5. From day 3 of culture, 30-50% of the human ESC colonies displayed a 
flattened morphology in their middle. Moreover, SOX2 overexpression in human ESCs 
induced upregulation of the trophectodermal markers EOMES and CDX2, but not of other 
lineage markers as determined by semi-quantitative RT-PCR and Q-PCR analysis (data not 
shown). After day 5, immunohistochemical staining showed that SOX2 overexpression in 
human ESCs resulted in trophectoderm differentiation. Exposure to Dox increased SOX2 
expression (Figure 2A); however, the levels of expression of OCT4 and NANOG, which are 
essential for maintenance of the undifferentiated state, decreased in these cells (Figure 2B-
C). Furthermore, SOX2 overexpression in human ESCs upregulated the expression of a 
differentiation cell surface marker SSEA-1 (Figure 2D). This result further supports the 
notion that SOX2 overexpression induces differentiation in human ESCs. We found that 
there was a substantial increase in the expression of the trophectoderm marker cytokeratin 8 
(Figure 2E), but there were no significant increases in expression of the endoderm marker 
GATA6, the ectoderm marker PAX6 or the mesoderm marker brachyury (data not shown). 
Finally, we found that CDX2 expression could be detected in cells with the morphological 
appearance of trophectoderm, consistent with our Q-PCR results. Following a further 2 days 
induction (day 7), we found that the number of cells expressing CGα increase more than 10-
fold (Fig. 2G). Interestingly, immunohistochemical staining did not detect increases in other 
trophectodermal, placental lactogen positive cells among SOX2-overexpressing cells (data 
not shown).  
Taken together, our observations indicate that overexpression of SOX2 in human ESCs 
resulted in trophectodermal differentiation accompanied by increased CDX2 expression. On 
the basis of the decrease in expression of OCT4 and NANOG, the increase in expression of 
trophectoderm markers, and the absence of a significant increase in expression of other 
lineage markers, we concluded that overexpression of SOX2 in human ESCs causes 
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Fig. 2. Overexpression of SOX2 in human ESCs induces trophectodermal differentiation.  
Immunohistochemical staining at day 5 (A-F) or day 7 (G) after induction of SOX2 
overexpression. (A) DOX induces increased SOX2 expression compared to control human 
ESCs. (B, C) Overexpression of SOX2 repressed expression of the core transcription factors 
OCT4 (B) and NANOG (C) in human ESCs. (D) SOX2 overexpression in human ESCs 
resulted in upregulation of the differentiation marker SSEA-1. (E-G) Immunohistochemical 
staining of trophectoderm for cytokeratin 8, CDX2 and CGA. (E) Increased cytokeratin 8 
expression was induced by SOX2 overexpression compared to control cells. (F) CDX2 was 
only detected in human ESCs overexpressing SOX2. (G) A few CGA positive cells were 
present in control samples, but a more than 10 fold increase in positive cells with stronger 
fluorescence was present after SOX2 overexpression. Scale bars = 100 mm. Abbreviations: 
Dox, doxycycline; -Dox, without Dox in the medium; +Dox, with Dox in the medium; CGA, 
glycoprotein hormones alpha chain. This figure is adapted from (Adachi et al., 2010).   
2.1.3 Expansion of CDX2 positive cells from SOX2-overexpressing human ESCs 
Our investigation demonstrated that overexpression of SOX2 induced trophectoderm 
differentiation, which was accompanied by an increase in CDX2 expression. Cdx2 is 
essential for the maintenance of trophoblast stem (TS) cells in the mouse (Niwa et al., 2005). 
Therefore, we speculated whether overexpression of SOX2 in human ESCs could induce TS-
like cells and/or expansion of trophoblast cells under mouse TS cell culture conditions. At 
day 4, human ESCs that had been induced by Dox to overexpress SOX2 started to change 
morphologically, to resemble trophoblast-like cells prior to flattening. The cells continued to 
proliferate, while retaining immunohistochemically positive staining for CDX2 (Figure 3A, 
B). On rare occasions, CDX2 positive cells were found in wild type or non-Dox induced 
human ESCs (Figure 3B).   
CDX2 positive cells were detected for 3 to 4 weeks after Dox induction. Most of the CDX2 
positive cells formed a glandular epithelium-like structure on the feeder cells (Figure 3C I). 
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Cells that were morphologically similar to mouse TS-like cells surrounded these structures, 
but CDX2 expression was weak or undetectable by immunohistochemistry in the majority of 
the cells (data not shown). A minority of the cells was CDX2 positive, and may represent 
candidate human TS cells (Figure 3C II). The numbers of other trophoblast cells that were 
positive for CGα immunohistochemical staining (data not shown) also greatly increased. 
Thus, under mouse TS cell culture conditions, overexpression of SOX2 in human ESCs 
resulted in an increase in the rate of differentiation of trophoblast cells. However, the 
majority of the trophoblast cells lost CDX2 expression, thereby preventing derivation of 
human TS cell lines. SOX2 overexpression was therefore not sufficient for maintenance of 
CDX2 expression in the TS-like cells. Instead, these culture conditions induced an increase in  
 
 
Fig. 3. Expansion of trophoblast and glandular epithelium cells from human ESCs by SOX2 
overexpression using the TS cell culture medium. 
(A) Initial morphological changes in trophoblast-like cells differentiating from human ESCs. 
Trophoblast-like cells were detectable at day 4 after induction of SOX2 overexpression. (B,C) 
Immunohistochemical staining for the trophectoderm marker CDX2. (B) CDX2 was only 
detected in human ESCs induced to overexpress SOX2. No CDX2 positive cells were present 
in parental cell lines or double transfected cell lines without Dox treatment. (C) CDX2 
positive cells were detected one month after Dox induction. (I) Glandular epithelium-like 
cells, (II) putative TS-like cells. Scale bars = 100 mm.  
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the number of CDX2 positive putative glandular epithelium-like cells, which showed more 
rapid proliferation than putative TS cells. Glandular differentiation did not occur only in 
response to SOX2 overexpression in human ESCs, suggesting that initiation of glandular 
epithelium differentiation is not related to SOX2 overexpression.   
2.2 Increased SOX2 expression in human ESCs induces differentiation of neural and 
glandular epithelium  
The teratoma formation assay has often been used to investigate the developmental 
potential of ESCs. We, therefore, used this assay to determine whether SOX2 overexpression 
in human ESCs enabled formation of trophoblastic tumors or caused them to develop into 
other tissues. To examine the effect of SOX2 overexpression during human ESC 
differentiation, we injected the double-transfected ES clones (lines #14 and #27) 
subcutaneously into the backs of SCID mice and monitored their differentiation with or 
without Dox treatment. Under this system, SOX2 should be an effective inducer of 
differentiation not only for human ESCs but also their differentiated descendants (Figure 
4A) Parental human ESC lines formed teratomas comprised of all three germ layers in the 
presence or absence of Dox treatment (Suemori et al., 2006; data not shown). Similarly, 
double-transfected ES clones formed teratomas comprised of all three germ layers in the 
absence of Dox treatment (Figure 4B, data not shown). However, after Dox treatment (i.e. 
SOX2 overexpression conditions), the double-transfected ES clones did not form teratomas 
like those observed in the absence of Dox. In this case, the teratomas were mainly comprised 
of neural epithelium and glandular epithelium (Figure 4C). We were unable to investigate 
how glandular epithelium differentiated from human ESCs. Glandular epithelium can 
differentiate from extraembryonic trophoblastic tissue and also the embryo proper, such as 
from gut or lung tissues, where SOX2 is expressed during development. Our results from 
use of the mouse TS cell culture protocol indicated that glandular epithelium could 
differentiate from human ESCs with or without SOX2 overexpression, and may suggest that 
SOX2 increases expansion of cell numbers rather than inducing initial differentiation.  
By contrast to culture of mouse ESCs, we had to remove differentiated colonies to enable 
continual culture of human ESCs. As described earlier, we did not detect any cells at day 5 
that were positive for the neuronal marker PAX6 among SOX2-overexpressing human ESCs. 
Two days later, PAX6-positive cells could be detected but only in the piled-up, embryoid 
body-like differentiated colonies formed by SOX2-overexpressing cells (K.A. and E.K., 
unpublished observation). We believe that SOX2 overexpression promoted expansion of 
PAX6-positive neural cells or neural progenitors rather than neuronal differentiation from 
human ESCs. In combination with our cell culture data, these observations indicated that 
overexpression of SOX2 enhanced specific-lineage development of neural and glandular 
epithelium in differentiating human ESCs.  
2.3 A putative model of SOX2 function in human ESCs 
We have shown that the regulated expression of SOX2 plays an important role in the 
maintenance of pluripotency in human ESCs. Decrease or increase of the level of SOX2 
expression resulted in human ESCs differentiating into the trophectodermal lineage. 
However, our results also suggest that trophectodermal differentiation may occur through 
different pathways. Although trophectoderm genes were upregulated in human ESCs with 
either repression or overexpression of SOX2, as determined by mRNA and protein studies, 
CDX2 expression was exceptional and seemed to alter in concert with the level of expression 
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of SOX2. Overexpression of either CDX2 or EOMES induces differentiation of mouse ESCs 
into the trophectoderm lineage (Niwa et al., 2005). OCT4 and SOX2 are known to interact 
physically and co-occupy many sites in ES cells, including those on the EOMES gene (Boyer 
et al., 2005). In our study, EOMES was significantly upregulated upon SOX2 repression in 
human ESCs, whereas CDX2 was not, suggesting that induction of EOMES by SOX2 
repression in human ESCs may be a key step in trophectodermal differentiation. In contrast, 
overexpression of SOX2 in human ESCs and activation of CDX2 expression may be key for 
trophectodermal differentiation. In this study, we found that SOX2 overexpression in 
human ESCs resulted in decreased expression of OCT4 and NANOG, leading to activation 
of trophectodermal genes. Indeed, OCT4 repression induces CDX2 and EOMES expression 
in human ESCs (Babaie et al., 2007; K.A. and E.K., unpublished data). It will be interesting to 
determine how SOX2 overexpression reduces stem cell related genes while, at the same  
 
 
Fig. 4. Induction of teratomas by transplantation of human ESCs overexpressing SOX2.  
(A) SOX2 overexpression was effective for both human ES cells and their descendants. (B) In 
the absence of Dox, human ESCs generated teratomas composed of all three germ layers. (C) 
SOX2 overexpressing ESCs induced by Dox in drinking water produced teratomas 
composed mainly of neuronal and glandular epithelium-like tissue. Scale bars = 100 mm.  
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time, increasing trophectodermal lineage genes. Elucidation of this process may provide 
novel insights into the gene regulatory networks for human ESC maintenance and 
differentiation. 
3. Conclusion 
In summary, the regulation of SOX2 expression is essential for maintaining the pluripotent 
state of human ESCs. Both SOX2 downregulation and upregulation caused trophectodermal 
differentiation. SOX2 overexpression also promoted neural and glandular epithelium 
tissues during human ESC differentiation as a late or secondary effect. Our results 
demonstrate that in human ESCs, SOX2 plays an important role in the maintenance of 
pluripotency and, possibly, trophoblast, neural and glandular epithelium development.   
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